Stem Cell Transplants Promising in ALS

Injections of stem cells that are induced to secrete neurotrophic factors in patients with amyotrophic lateral sclerosis (ALS) are safe, well tolerated, and possibly clinically beneficial, results of a small open-label study suggest.

Although the results have to be confirmed with a clinical trial, they are “ground-breaking” and open the door for this line of investigation, author Dimitrios Karussis, MD, PhD, a neuro-immunology expert and professor, Neurology Department, Hadassah-Hebrew University Medical Center, Jerusalem, Israel, told Medscape Medical News.